Astellas Taps Pfizer Exec To Run New Global Development HQ
This article was originally published in PharmAsia News
Executive Summary
Long-time Pfizer exec Steven Ryder will become president of Astellas Pharma's new headquarters for global development in Deerfield, Ill., effective April 1, the Tokyo-based company announced March 4
You may also be interested in...
U.S. FDA Lifts Clinical Holds On Anemia Compounds Under Development By Astellas/FibroGen
FDA has deemed FibroGen's response to a clinical hold on two oral anemia therapy candidates complete, allowing Phase II trials of the compounds to resume, FibroGen's development partner, Astellas Pharma, announced April 2
U.S. FDA Lifts Clinical Holds On Anemia Compounds Under Development By Astellas/FibroGen
FDA has deemed FibroGen's response to a clinical hold on two oral anemia therapy candidates complete, allowing Phase II trials of the compounds to resume, FibroGen's development partner, Astellas Pharma, announced April 2
Analysts View Astellas’ Pick Of Former Pfizer Exec To Head Global Development As Nod To Daiichi Sankyo's Success
TOKYO - Astellas Pharma's decision to move its global development headquarters to Illinois may be a reflection of how other major Japanese pharmas see Daiichi Sankyo's position in the market, a Japanese analyst says